NxStage Medical Inc.
NXTM
NXTM was delisted on the 21st of February, 2019.
147 hedge funds and large institutions have $1.38B invested in NxStage Medical Inc. in 2016 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 43 increasing their positions, 55 reducing their positions, and 20 closing their positions.
1,116% more call options, than puts
Call options by funds: $997K | Put options by funds: $82K
60% more funds holding in top 10
Funds holding in top 10: 5 → 8 (+3)
51% more capital invested
Capital invested by funds: $913M → $1.38B (+$466M)
35% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 20
5% more funds holding
Funds holding: 140 → 147 (+7)
22% less repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 55
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$54.2M |
| 2 |
PA
Perceptive Advisors
New York
|
+$24.7M |
| 3 |
CCM
Consonance Capital Management
New York
|
+$14.9M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$8.54M |
| 5 |
PC
Polar Capital
London,
United Kingdom
|
+$6.69M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RIM
RS Investment Management
San Francisco,
California
|
-$18.3M |
| 2 |
DM
Deerfield Management
New York
|
-$17.9M |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$9.67M |
| 4 |
TA
Tamarack Advisers
Carlsbad,
California
|
-$8.92M |
| 5 |
CCM
Cadian Capital Management
New York
|
-$7.25M |
NXTM Hedge Fund Activity: Q2 2016 in Review
147 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in NxStage Medical Inc. (NXTM) for Q2 2016, worth a combined $1.38B — up 51% from $913M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new NXTM positions and 20 closed out — a net gain of 7 holders — while 43 added to existing stakes and 55 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $54.2M. The largest seller was RS Investment Management, cutting an estimated $18.3M.
- 147 institutional investors held NxStage Medical Inc. (NXTM) as of Q2 2016, up from 140 in Q1 2016.
- Funds reported $1.38B of NxStage Medical Inc. stock for Q2 2016, up 51% quarter-over-quarter.
- 27 funds opened new NxStage Medical Inc. positions in Q2 2016 and 20 closed out, a net change of +7 holders.
- The largest NxStage Medical Inc. buyer in Q2 2016 was Fidelity Investments, an estimated $54.2M added.
- The largest NxStage Medical Inc. seller in Q2 2016 was RS Investment Management, an estimated $18.3M sold.
Based on aggregated 13F filings for Q2 2016.